Navigation Links
NUS researchers discover novel protein complex with potential to combat gastric cancer
Date:7/7/2014

A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) discovered that a protein named IL23A is part of our stomach's defence against bacterial infection which leads to gastric cancer. This finding could potentially be used to combat the deadly disease.

The research group, led by Professor Yoshiaki Ito, Senior Principal Investigator at CSI Singapore, also showed that the production of IL23A by stomach cells requires the tumour suppressor gene, RUNX3, which is frequently silenced in gastric cancer. The novel study was first published online in the leading journal Cell Reports on 4 July 2014.

Every year, some 740,000 people die from gastric cancer globally. In Singapore, stomach cancer was the fourth leading cause of cancer death among men and fifth among women from 2008 to 2012. This highlights the urgent need to understand the causes of this deadly disease. It is now known that a major trigger for the development of gastric cancer is the infection of a bacterium, Helicobacter pylori. A drawn-out battle against this bacterium often causes persistent inflammation of the stomach, which is a dangerous cancer-causing condition. As such, understanding and strengthening the natural defence mounted by our stomach cells is a logical and crucial step in preventing gastric cancer.

In this study, the researchers found that a protein named IL23A normally produced only by white blood cells is released by stomach cells when exposed to H. pylori. This demonstrates that IL23A is part of our stomach's defence against bacterial infection. At the same time, they found that production of IL23A by stomach cells requires RUNX3, a tumour suppressor gene that is frequently silenced in gastric cancer. The involvement of RUNX3 appears particularly important during inflammation and infection caused by the bacterium. Their observation makes an important connection: when stomach cells lose RUNX3, they become defective in their ability to respond to infection by H. pylori, making the stomach vulnerable to this carcinogenic bacterium.

Prof Ito said, "We have been studying the frequent inactivation of RUNX3 in gastric cancer for some time. Our latest findings show that an important consequence of losing RUNX3 is a compromised immunity and this will enable us to devise better protection against pathogens."

The study was supported by the Translational and Clinical Research Flagship Programme and the National Research Foundation of Singapore.

In the next phase of research, the team will focus on determining the function of the novel IL23A complex they discovered, as part of their overall strategy to combat H. pylori-induced gastric cancer. Concomitant application for patent protection of this work by NUS will facilitate industry involvement, so that this research can be effectively used to develop novel treatments to combat gastric cancer.


'/>"/>

Contact: Kimberley Wang
kimberley.wang@nus.edu.sg
National University of Singapore
Source:Eurekalert

Related medicine news :

1. NYU researchers find 18 percent of high school seniors smoke hookah
2. The Lancet: Sierra Leone researchers call for improved health surveillance and communication around Ebola crisis
3. GW researchers: Acute kidney injury and chronic kidney disease as interconnected syndromes
4. Cleveland Clinic researchers identify urgent need for Alzheimers drug development
5. Mayo Clinic researchers reveal treasure trove of genes key to kidney cancer
6. Researchers seek to tackle transplant tolerance using patients own T cells
7. Moffitt researchers develop new way to combat drug resistance for melanoma patients
8. Researchers estimate 5.8 million A&E visits occur after patients unable to see a GP
9. Researchers conduct comprehensive review of treatments for depression in cancer patients
10. Miriam Hospital researchers develop app focused on making obese adults less sedentary
11. Researchers home in on way to predict aggressiveness of oral cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... surgery as possible. With this in mind, SIGVARIS has created a new line ... clot) during bed rest and provide the benefits of graduated compression when transitioning ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital ... B led by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) ... platform to serve more consumers who are managing chronic conditions or simply ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... planning services from offices headquartered in Hamilton County, is embarking on a charity ... LuvFurMutts specializes in finding new homes for orphaned or neglected senior dogs in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/8/2016)... Bay St. Louis, MS (PRWEB) , ... December 08, 2016 , ... ... with offices that serve commercial and residential clients in and around the Hancock County ... community support for the Hancock County Food Pantry. , The Hancock County Food Pantry ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- Boehringer Ingelheim announced today that it has been recognized ... the ninth time that the company received a perfect ... to Work for LGBT Equality. Administered by the Human ... report on corporate policies and practices related to workplace ... "We are committed to creating an ...
(Date:12/8/2016)... December 8, 2016 According ... Market by Product (Actual Sugars, Sugar Alcohols, Artificial ... Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - ... market has witnessed healthy growth during the last ... CAGR of 4.3% between 2016 and 2021 to ...
(Date:12/8/2016)... According to a new market research report "Wearable Medical Devices ... End Use (Sports, Fitness, RPM), Type (Smart watch, Patch), Distribution Channel (Pharmacy, ... terms of value, is projected to reach 12.14 Billion by 2021 from ... forecast period. Continue Reading ... ...
Breaking Medicine Technology: